Letters To The Editor
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 28, 2014; 20(28): 9631-9632
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9631
Neutrophil-lymphocyte ratio is useful for the prognosis of patients with hepatocellular carcinoma
Huseyin Kayadibi, Erdim Sertoglu, Metin Uyanik, Serkan Tapan
Huseyin Kayadibi, Department of Medical Biochemistry, Adana Military Hospital, Adana 01150, Turkey
Erdim Sertoglu, Biochemistry Laboratory of Anittepe Dispensary, Ankara Mevki Military Hospital, Ankara 06580, Turkey
Metin Uyanik, Serkan Tapan, Department of Medical Biochemistry, GATA School of Medicine, Ankara 06018, Turkey
Author contributions: Kayadibi H, Sertoglu E and Uyanik M wrote this letter; Tapan S revised the letter.
Correspondence to: Huseyin Kayadibi, MD, MSc, Department of Medical Biochemistry, Adana Military Hospital, Seyhan, 01150 Adana, Turkey. mdkayadibi@yahoo.com
Telephone: +90-544-6178931 Fax: +90-322-2272338
Received: January 25, 2013
Revised: February 23, 2014
Accepted: April 5, 2014
Published online: July 28, 2014
Core Tip

Core tip: Neutrophil-lymphocyte ratio (NLR), total tumor size (> 9 cm) and macro-vascular invasion may play a role in the prediction of recurrence in patients with hepatitis B virus-related hepatocellular carcinoma after liver transplantation. Assessment of both NLR and platelet-lymphocyte ratio, as inflammation markers, may increase the prediction rate for these patients. Factors affecting the laboratory results should also be evaluated, in such a study.